Each brand is FDA-approved for one or more of these conditions
[17] [20] En el estmago, GLP-1 inhibe el vaciamiento gstrico, la secrecin de cido y la motilidad, lo que en conjunto disminuye el apetito
Synergistic combined effect of drugs induces cell cycle arrest, apoptosis, and alteration to mitochondrial membrane potential in cancer cells as well as down regulates the expression of CD44 receptor, which are main factor for cancer metastasis
In addition, when acute metabolic disorders occur, treatment should be based on the principles of reversing catabolism and eliminating toxic metabolites, with glucose and fat milk supplementation to reverse catabolism, carnitine supplementation, and hemodialysis or peritoneal dialysis for the removal of toxic compounds